Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash from operating activities:    
Net loss $ (3,049,691) $ (744,842)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 136,108 71,318
Stock based compensation 35,017 403,070
Interest expense related to debt discounts 9,401
Changes in assets and liabilities:    
Accounts receivable 124,810 (1,093,143)
Contract assets 379,136 76,228
Prepaid expenses and other current assets (562,263) 58,934
Operating lease right of use asset (509,958)
Accounts payable 461,701 168,692
Related payable-related party (682) 875
Payroll taxes payable (195,120) 50,671
Accrued expenses 27,804 17,523
Operating lease obligation 534,415
Contract liabilities (1,141,088) 1,057,747
Deferred revenue 126,534 (159,532)
Net cash used in operating activities (3,623,876) (92,459)
Cash flows from investing activities:    
Software development costs (60,000)
Purchase of patents/trademarks (11,595) (5,500)
Purchase of fixed assets (133,039) (157,804)
Net cash used in investing activities (144,634) (223,304)
Cash flows from financing activities:    
Repurchase of common stock (7,993)
Repayments of line of credit (2,689) (2,997)
Repayments of related party notes (80,000) (48,215)
Issuance cost (10,000)
Repayments of insurance and equipment financing (207,187) (197,792)
Payments of financial lease (10,851)
Proceeds from notes payable-related parties 1,080,000
Proceeds from notes payable 250,000
Proceeds from warrants exercised 2,315,268 195,000
Net cash provided by (used in) financing activities 3,326,548 (54,004)
Net decrease in cash (441,962) (369,767)
Cash, beginning of period 1,209,301 1,941,818
Cash, end of period 767,339 1,572,051
Supplemental Disclosure of Cash Flow Information:    
Interest paid 5,728 7,411
Supplemental Non-Cash Investing and Financing Activities:    
Common stock issued for accrued BOD fees 19,166 73,708
Note issued for financing of insurance premiums 217,804 217,173
Debt discount on Notes issued 12,500
Note issued for equipment financing lease $ 102,928